Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.

Authors
Type
Published Article
Journal
Transplantation Journal
0041-1337
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
85
Issue
2
Pages
256–263
Identifiers
DOI: 10.1097/TP.0b013e31815e8926
PMID: 18212631
Source
Medline
License
Unknown

Abstract

SIR monotherapy is not sufficient to suppress rejection after transplantation under ATG, but it can maintain survival of established beta-cell grafts. However, the risk for a SIR-induced proteinuria remains a concern.

Statistics

Seen <100 times